{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:38Z","timestamp":1790957558152,"version":"4.1.0"},"reference-count":94,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RADDF"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The discovery of proteins and peptides marked the actual beginning for pharmaceutical\ncompanies to do research on novel delivery systems for delivering these therapeutic proteins. Biodegradable\npolymer-based microspheres for controlled-release depot injection are known for decades\nand have proved to be one of the best possible approaches. Despite being known for decades, the\ncommercial success of microsphere-based delivery systems remains limited. Very few products are\nseen in the market with no generics available for approved brand products whose patents have either\nexpired or are about to expire. All this points to the complexities involved in developing these delivery\nsystems. Still, many hurdles remain in developing these drug delivery systems namely, poor drug entrapment,\nunwanted burst release, poor in vitro in vivo correlation, lack of proper in vitro testing\nmethods, problems involved during scale-up, and the most important hurdle being sterilization of the\nproduct. To achieve successful product development, all of these technical difficulties need to be simultaneously\ndealt with and resolved. This article attempts to highlight the problem areas for these delivery\nsystems along with the regulatory requirements involved and map the present status of these delivery\nsystems.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2667387817666230119103126","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T09:35:02Z","timestamp":1674120902000},"page":"13-30","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biodegradable Polymer-Based Microspheres for Depot Injection-Industry\nPerception"],"prefix":"10.2174","volume":"17","author":[{"given":"Anand","family":"Kyatanwar","sequence":"first","affiliation":[{"name":"Bharat Serums and Vaccines Ltd., R&amp;D Center, Airoli, Navi-Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangal","family":"Nagarsenker","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Vivekanand\nEducation Society\u2019s College of Pharmacy, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-4649","authenticated-orcid":true,"given":"Bala","family":"Prabhakar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SPP School of Pharmacy\n&amp; Technology Management, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijms20102383","volume":"20","author":"Lee A.C.L.","year":"2019","unstructured":"Lee A.C.L.; Harris J.L.; Khanna K.K.; Hong J.H.; A comprehensive review on current advances in peptide drug development and design. Int J Mol Sci 2019,20(10),2383","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12100999","volume":"12","author":"Ibeanu N.","year":"2020","unstructured":"Ibeanu N.; Egbu R.; Onyekuru L.; Injectables and depots to prolong drug action of proteins and peptides. Pharmaceutics 2020,12(10),1-42","journal-title":"Pharmaceutics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.47391\/JPMA.759","volume":"71","year":"2021","unstructured":"Saba Saeed , Mavra Irfan , Saima Naz , Momil Liaquat , Shafaq Jahan , Sana Hayat. Routes and barriers associated with protein and peptide drug delivery system. J Pak Med Assoc 2021,71(8),2032-2039","journal-title":"J Pak Med Assoc"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"Patra J.K.","year":"2018","unstructured":"Patra J.K.; Das G.; Fraceto L.F.; Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 2018,16(1),71","journal-title":"J Nanobiotechnology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.3390\/ijms22168884","volume":"22","author":"Butreddy A.","year":"2021","unstructured":"Butreddy A.; Gaddam R.P.; Kommineni N.; Dudhipala N.; Voshavar C.; PLGA\/PLA-based long-acting injectable depot microspheres in clinical use: Production and characterization overview for protein\/peptide delivery. Int J Mol Sci 2021,22(16),8884","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/molecules26195905","volume":"26","author":"Adepu S.","year":"2021","unstructured":"Adepu S.; Ramakrishna S.; Controlled drug delivery systems: current status and future directions. Molecules 2021,26(19),5905","journal-title":"Molecules"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/molecules23040907","volume":"23","author":"Olusanya T.","year":"2018","unstructured":"Olusanya T.; Haj Ahmad R.; Ibegbu D.; Smith J.; Elkordy A.; Liposomal drug delivery systems and anticancer drugs. Molecules 2018,23(4),907","journal-title":"Molecules"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/9783110640571-001","author":"Burke G.","year":"2019","unstructured":"Burke G.; Kenny E.; Dalton M.; 1 Biodegradation and biodegradable polymers. bioresorbable polymers; boston: Walter de Gruyter GmbH 2019,1-16","journal-title":"bioresorbable polymers; boston: Walter de Gruyter GmbH"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"85124","DOI":"10.5772\/intechopen.85124","volume":"2019","author":"Glaser A.","year":"2019","unstructured":"Glaser A.; Biological degradation of polymers in the environment. Plast Environ 2019,2019,85124","journal-title":"Plast Environ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.15171\/bi.2017.09","volume":"7","author":"Namazi H.","year":"2017","unstructured":"Namazi H.; Polymers in our daily life. Bioimpacts 2017,7(2),73-74","journal-title":"Bioimpacts"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13019-020-1041-5","volume":"15","author":"Ni L.","year":"2020","unstructured":"Ni L.; Chen H.; Luo Z.; Yu Y.; Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis. J Cardiothorac Surg 2020,15(1),26","journal-title":"J Cardiothorac Surg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1098\/rsif.2010.0223","volume":"8","author":"Lee K.","year":"2011","unstructured":"Lee K.; Silva E.A.; Mooney D.J.; Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011,8(55),153-170","journal-title":"J R Soc Interface"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2020.10.022","volume":"158","author":"Scheiner K.C.","year":"2021","unstructured":"Scheiner K.C.; Maas-Bakker R.F.; van Steenbergen M.J.; Schwendeman S.P.; Hennink W.E.; Kok R.J.; Post-loading of proangiogenic growth factors in PLGA microspheres. Eur J Pharm Biopharm 2021,158(158),1-10","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4240\/wjgs.v6.i12.241","volume":"6","author":"Sajid M.S.","year":"2014","unstructured":"Sajid M.S.; McFall M.R.; Whitehouse P.A.; Sains P.S.; Systematic review of absorbable vs. non-absorbable sutures used for the closure of surgical incisions. World J Gastrointest Surg 2014,6(12),241-247","journal-title":"World J Gastrointest Surg"},{"key":"ref=15","unstructured":"U.S. Food and Drug Administration. Orange book: Approved drug products with therapeutic equivalence evaluations. Available from:\n (Accessed on: Jun 1, 2022)."},{"key":"ref=16","unstructured":"U.S. Food and Drug Administration. Inactive Ingredient Search for Approved Drug Products.  Available from:\n (Accessed on: Jun 1, 2022)."},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.aiepr.2020.01.002","volume":"3","author":"Jem K.J.","year":"2020","unstructured":"Jem K.J.; Tan B.; The development and challenges of poly (lactic acid) and poly (glycolic acid). Adv Indus Eng Polym Res 2020,3(2),60-70","journal-title":"Adv Indus Eng Polym Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3390\/polym13111822","volume":"13","author":"Balla E.","year":"2021","unstructured":"Balla E.; Daniilidis V.; Karlioti G.; Poly(lactic Acid): A versatile biobased polymer for the future with multifunctional properties\u2014from monomer synthesis, polymerization techniques and molecular weight increase to PLA applications. Polymers (Basel) 2021,13(11),1822","journal-title":"Polymers (Basel)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","volume":"9","author":"Li C.","year":"2019","unstructured":"Li C.; Wang J.; Wang Y.; Recent progress in drug delivery. Acta Pharm Sin B 2019,9(6),1145-1162","journal-title":"Acta Pharm Sin B"},{"key":"ref=20","author":"Sin L.T.","year":"2019","unstructured":"Sin L.T.; Tueen B.S.;  Polylactic acid: A practical guide for the processing, manufacturing, and applications of PLA 2019","journal-title":"Polylactic acid: A practical guide for the processing, manufacturing, and applications of PLA"},{"key":"ref=21","unstructured":"USFDA. List of Drug Master Files (DMFs).  Available from:\n (Accessed on: Jun 1, 2022)."},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00586-005-1003-6","volume":"15","author":"Wuisman P.I.J.M.","year":"2006","unstructured":"Wuisman P.I.J.M.; Smit T.H.; Bioresorbable polymers: heading for a new generation of spinal cages. Eur Spine J 2006,15(2),133-148","journal-title":"Eur Spine J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1039\/9781788016483-00001","author":"Saalw\u00e4chter K.","year":"2019","unstructured":"Saalw\u00e4chter K.; Applications of NMR in polymer characterization - An introduction. NMR methods for characterization of synthetic and natural polymers 2019,1-22","journal-title":"NMR methods for characterization of synthetic and natural polymers"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/ed100461v","volume":"88","author":"Izunobi J.U.","year":"2011","unstructured":"Izunobi J.U.; Higginbotham C.L.; Polymer molecular weight analysis by 1 H NMR spectroscopy. J Chem Educ 2011,88(8),1098-1104","journal-title":"J Chem Educ"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s13346-021-01023-3","volume":"12","author":"Sun J.","year":"2022","unstructured":"Sun J.; Walker J.; Beck-Broichsitter M.; Schwendeman S.P.; Characterization of commercial PLGAs by NMR spectroscopy. Drug Deliv Transl Res 2022,12(3),720-729","journal-title":"Drug Deliv Transl Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"17359","DOI":"10.1039\/C8NJ02441C","volume":"42","author":"Li Y.","year":"2018","unstructured":"Li Y.; Dang Y.; Han D.; An Angiopep-2 functionalized nanoformulation enhances brain accumulation of tanshinone IIA and exerts neuroprotective effects against ischemic stroke. New J Chem 2018,42(21),17359-17370","journal-title":"New J Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40204-020-00139-y","volume":"9","author":"Lagreca E.","year":"2020","unstructured":"Lagreca E.; Onesto V.; Di Natale C.; La Manna S.; Netti P.A.; Vecchione R.; Recent advances in the formulation of PLGA microparticles for controlled drug delivery. Prog Biomater 2020,9(4),153-174","journal-title":"Prog Biomater"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/pharmaceutics11120627","volume":"11","author":"Park H.","year":"2019","unstructured":"Park H.; Ha D.H.; Ha E.S.; Kim J.S.; Kim M.S.; Hwang S.J.; Effect of stabilizers on encapsulation efficiency and release behavior of exenatide-loaded PLGA microsphere prepared by the W\/O\/W solvent evaporation method. Pharmaceutics 2019,11(12),627","journal-title":"Pharmaceutics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2000149","DOI":"10.1002\/marc.202000149","volume":"41","author":"Zhou L.","year":"2020","unstructured":"Zhou L.; Shi H.; Li Z.; He C.; Recent advances in complex coacervation design from macromolecular assemblies and emerging applications. Macromol Rapid Commun 2020,41(21),2000149","journal-title":"Macromol Rapid Commun"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1039\/D0SM00001A","volume":"16","author":"Sing C.E.","year":"2020","unstructured":"Sing C.E.; Perry S.L.; Recent progress in the science of complex coacervation. Soft Matter 2020,16(12),2885-2914","journal-title":"Soft Matter"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejpb.2021.11.007","volume":"170","author":"van der Kooij R.S.","year":"2022","unstructured":"van der Kooij R.S.; Steendam R.; Frijlink H.W.; Hinrichs W.L.J.; An overview of the production methods for core\u2013shell microspheres for parenteral controlled drug delivery. Eur J Pharm Biopharm 2022,170(170),24-42","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jsamd.2020.09.001","volume":"5","author":"Galogahi F.M.","year":"2020","unstructured":"Galogahi F.M.; Zhu Y.; An H.; Nguyen N.T.; Core-shell microparticles: Generation approaches and applications. J Sci Adv Mater Devices 2020,5(4),417-435","journal-title":"J Sci Adv Mater Devices"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40005-019-00441-3","volume":"49","author":"Arpagaus C.","year":"2019","unstructured":"Arpagaus C.; PLA\/PLGA nanoparticles prepared by nano spray drying. J Pharm Investig 2019,49(4),405-426","journal-title":"J Pharm Investig"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"677547","DOI":"10.3389\/fmolb.2021.677547","volume":"8","author":"Damiati S.A.","year":"2021","unstructured":"Damiati S.A.; Damiati S.; Microfluidic synthesis of indomethacin-loaded PLGA microparticles optimized by machine learning. Front Mol Biosci 2021,8,677547","journal-title":"Front Mol Biosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1039\/C8RA08972H","volume":"9","author":"Rezvantalab S.","year":"2019","unstructured":"Rezvantalab S.; Keshavarz Moraveji M.; Microfluidic assisted synthesis of PLGA drug delivery systems. RSC Advances 2019,9(4),2055-2072","journal-title":"RSC Advances"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0251821","volume":"16","author":"Mares A.G.","year":"2021","unstructured":"Mares A.G.; Pacassoni G.; Marti J.S.; Pujals S.; Albertazzi L.; Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology. PLoS One 2021,16,1-18","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/B978-0-12-816505-8.00016-3","author":"Gaikwad V.L.","year":"2019","unstructured":"Gaikwad V.L.; Choudhari P.B.; Bhatia N.M.; Bhatia M.S.; Characterization of pharmaceutical nanocarriers: In vitro and in vivo studies. nanomaterials for drug delivery and therapy 2019,33-58","journal-title":"nanomaterials for drug delivery and therapy"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"Danaei M.","year":"2018","unstructured":"Danaei M.; Dehghankhold M.; Ataei S.; Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 2018,10(2),57","journal-title":"Pharmaceutics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"eabb6594","DOI":"10.1126\/sciadv.abb6594","volume":"6","author":"Sarmadi M.","year":"2020","unstructured":"Sarmadi M.; Behrens A.M.; McHugh K.J.; Modeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulations. Sci Adv 2020,6(28),eabb6594","journal-title":"Sci Adv"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijpharm.2015.08.063","volume":"495","author":"Garner J.","year":"2015","unstructured":"Garner J.; Skidmore S.; Park H.; Park K.; Choi S.; Wang Y.; A protocol for assay of poly(lactide-co-glycolide) in clinical products. Int J Pharm 2015,495(1),87-92","journal-title":"Int J Pharm"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/pharmaceutics13081313","volume":"13","author":"Kim Y.","year":"2021","unstructured":"Kim Y.; Park E.J.; Kim T.W.; Na D.H.; Recent progress in drug release testing methods of biopolymeric particulate system. Pharmaceutics 2021,13(8),1313","journal-title":"Pharmaceutics"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ijpharm.2015.08.089","volume":"495","author":"Gu B.","year":"2015","unstructured":"Gu B.; Burgess D.J.; Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach. Int J Pharm 2015,495(1),393-403","journal-title":"Int J Pharm"},{"key":"ref=43","unstructured":"ICH Harmonised Guideline - Impurities: Guideline for Residual Solvents Q3C(R8). Available from:\n (Accessed on: Jun 1, 2022)."},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/acs.molpharmaceut.0c01089","volume":"18","author":"Park K.","year":"2021","unstructured":"Park K.; Otte A.; Sharifi F.; Potential roles of the glass transition temperature of PLGA microparticles in drug release kinetics. Mol Pharm 2021,18(1),18-32","journal-title":"Mol Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"119339","DOI":"10.1016\/j.ijpharm.2020.119339","volume":"582","author":"Kohno M.","year":"2020","unstructured":"Kohno M.; Andhariya J.V.; Wan B.; The effect of PLGA molecular weight differences on risperidone release from microspheres. Int J Pharm 2020,582,119339","journal-title":"Int J Pharm"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pi.2748","volume":"59","author":"Stepto R.F.T.","year":"2010","unstructured":"Stepto R.F.T.; Dispersity in polymer science (IUPAC Recommendation 2009). Polym Int 2010,59(1),23-24","journal-title":"Polym Int"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/polym10020158","volume":"10","author":"Manas D.","year":"2018","unstructured":"Manas D.; Ovsik M.; Mizera A.; The effect of irradiation on mechanical and thermal properties of selected types of polymers. Polymers (Basel) 2018,10(2),158","journal-title":"Polymers (Basel)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.7150\/ijms.22644","volume":"15","author":"Harrell C.R.","year":"2018","unstructured":"Harrell C.R.; Djonov V.; Fellabaum C.; Volarevic V.; Risks of using sterilization by gamma radiation: The other side of the coin. Int J Med Sci 2018,15(3),274-279","journal-title":"Int J Med Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.22270\/jddt.v8i5.1829","volume":"8","author":"Sheena U.","year":"2018","unstructured":"Sheena U.; Parthiban K.G.; Selvakumar R.; Lyophilized injection: a modern approach of injectable dosage form. J Drug Deliv Ther 2018,8(5),10-18","journal-title":"J Drug Deliv Ther"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1208\/ps060111","volume":"6","author":"Burgess D.J.","year":"2004","unstructured":"Burgess D.J.; Crommelin D.J.A.; Hussain A.S.; Chen M.L.; Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS PharmSci 2004,6(1),100-111","journal-title":"AAPS PharmSci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1208\/s12249-011-9625-y","volume":"12","author":"Cilurzo F.","year":"2011","unstructured":"Cilurzo F.; Selmin F.; Minghetti P.; Injectability evaluation: an open issue. AAPS PharmSciTech 2011,12(2),604-609","journal-title":"AAPS PharmSciTech"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/nano10020266","volume":"10","author":"Dalzon B.","year":"2020","unstructured":"Dalzon B.; Torres A.; Reymond S.; Influences of nanoparticles characteristics on the cellular responses: The example of iron oxide and macrophages. Nanomaterials (Basel) 2020,10(2),266","journal-title":"Nanomaterials (Basel)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/pharmaceutics12111032","volume":"12","author":"Marante T.","year":"2020","unstructured":"Marante T.; Viegas C.; Duarte I.; Macedo A.S.; Fonte P.; An overview on spray-drying of protein-loaded polymeric nanoparticles for dry powder inhalation. Pharmaceutics 2020,12(11),1032","journal-title":"Pharmaceutics"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.febslet.2014.05.006","volume":"588","author":"Nick Pace C.","year":"2014","unstructured":"Nick Pace C.; Scholtz J.M.; Grimsley G.R.; Forces stabilizing proteins. FEBS Lett 2014,588(14),2177-2184","journal-title":"FEBS Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0142-9612(00)00178-2","volume":"22","author":"Yang Y.","year":"2001","unstructured":"Yang Y.; Chung T.S.; Ng N.P.; Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction\/evaporation method. Biomaterials 2001,22(3),231-241","journal-title":"Biomaterials"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1007\/s00894-012-1507-z","volume":"19","author":"Khabiri M.","year":"2013","unstructured":"Khabiri M.; Minofar B.; Brezovsk\u00fd J.; Damborsk\u00fd J.; Ettrich R.; Interaction of organic solvents with protein structures at protein-solvent interface. J Mol Model 2013,19(11),4701-4711","journal-title":"J Mol Model"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","volume":"11","author":"Ratanji K.D.","year":"2014","unstructured":"Ratanji K.D.; Derrick J.P.; Dearman R.J.; Kimber I.; Immunogenicity of therapeutic proteins: Influence of aggregation. J Immunotoxicol 2014,11(2),99-109","journal-title":"J Immunotoxicol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","volume":"16","author":"Scheiblhofer S.","year":"2017","unstructured":"Scheiblhofer S.; Laimer J.; Machado Y.; Weiss R.; Thalhamer J.; Influence of protein fold stability on immunogenicity and its implications for vaccine design. Expert Rev Vaccines 2017,16(5),479-489","journal-title":"Expert Rev Vaccines"},{"key":"ref=59","unstructured":"U.S. Food and Drug Administration (FDA). Guidance for Industry: Immunogenicity assessment for therapeutic protein products. Available from:\n (Accessed on: Jun 1, 2022)."},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijpharm.2016.11.007","volume":"516","author":"Zhao J.","year":"2017","unstructured":"Zhao J.; Wang L.; Fan C.; Development of near zero-order release PLGA-based microspheres of a novel antipsychotic. Int J Pharm 2017,516(1-2),32-38","journal-title":"Int J Pharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"119006","DOI":"10.1016\/j.ijpharm.2019.119006","volume":"575","author":"Yang Z.","year":"2020","unstructured":"Yang Z.; Liu L.; Su L.; Design of a zero-order sustained release PLGA microspheres for palonosetron hydrochloride with high encapsulation efficiency. Int J Pharm 2020,575(575),119006","journal-title":"Int J Pharm"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/am.2013.26","volume":"5","author":"Huang C.L.","year":"2013","unstructured":"Huang C.L.; Steele T.W.J.; Widjaja E.; Boey F.Y.C.; Venkatraman S.S.; Loo J.S.C.; The influence of additives in modulating drug delivery and degradation of PLGA thin films. NPG Asia Mater 2013,5(7),e54","journal-title":"NPG Asia Mater"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","volume":"6","author":"Yoo J.","year":"2020","unstructured":"Yoo J.; Won Y.Y.; Phenomenology of the initial burst release of drugs from PLGA microparticles. ACS Biomater Sci Eng 2020,6(11),6053-6062","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=64","author":"Mayo J.","unstructured":"Mayo J.; Understanding the nutsche filtration and drying process process. Available from:\nunderstanding- the-nutsche-filtration-and-drying-process (Accessed on: Jun 1, 2022)."},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/019262339602400423","volume":"24","author":"Smith P.E.","year":"1996","unstructured":"Smith P.E.; Third international conference on harmonization of technical requirements for registration of pharmaceuticals for human use--a toxicologist\u2019s perspective. Toxicol Pathol 1996,24(4),519-528","journal-title":"Toxicol Pathol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijpharm.2011.02.057","volume":"409","author":"Rawat A.","year":"2011","unstructured":"Rawat A.; Burgess D.J.; USP apparatus 4 method for in vitro release testing of protein loaded microspheres. Int J Pharm 2011,409(1-2),178-184","journal-title":"Int J Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.08.118","volume":"532","author":"Rodrigues de Azevedo C.","year":"2017","unstructured":"Rodrigues de Azevedo C.; von Stosch M.; Costa M.S.; Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics. Int J Pharm 2017,532(1),229-240","journal-title":"Int J Pharm"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics12010036","volume":"12","author":"Lee D.S.","year":"2020","unstructured":"Lee D.S.; Kang D.W.; Choi G.W.; Choi H.G.; Cho H.Y.; Development of level a in vitro\u2013vivo correlation for electrosprayed microspheres containing leuprolide: Physicochemical, pharmacokinetic, and pharmacodynamic evaluation. Pharmaceutics 2020,12(1),36","journal-title":"Pharmaceutics"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.07.013","volume":"308","author":"Andhariya J.V.","year":"2019","unstructured":"Andhariya J.V.; Jog R.; Shen J.; Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. J Control Release 2019,308,1-13","journal-title":"J Control Release"},{"key":"ref=70","first-page":"4","volume":"20","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Qu W.; Choi S.H.; FDA\u2019s regulatory science program for generic PLA\/PLGA-based drug products. Am Pharm Rev 2016,20,4","journal-title":"Am Pharm Rev"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11596-020-2185-1","volume":"40","author":"Guan Y.","year":"2020","unstructured":"Guan Y.; Wang L.; Wang B.; Ding M.; Bao Y.; Tan S.; Recent advances of D-\u03b1-tocopherol polyethylene glycol 1000 Succinate based stimuli-responsive nanomedicine for cancer treatment. Curr Med Sci 2020,40(2),218-231","journal-title":"Curr Med Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1021\/acs.iecr.1c00063","volume":"60","author":"Si W.","year":"2021","unstructured":"Si W.; Yang Q.; Zong Y.; Toward understanding the effect of solvent evaporation on the morphology of PLGA microspheres by double emulsion method. Ind Eng Chem Res 2021,60(25),9196-9205","journal-title":"Ind Eng Chem Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0378-5173(00)00574-3","volume":"212","author":"Chung T.W.","year":"2001","unstructured":"Chung T.W.; Huang Y.Y.; Liu Y.Z.; Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres. Int J Pharm 2001,212(2),161-169","journal-title":"Int J Pharm"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"13262","DOI":"10.1021\/acs.langmuir.7b01985","volume":"33","author":"Zhou F.L.","year":"2017","unstructured":"Zhou F.L.; Chirazi A.; Gough J.E.; Hubbard Cristinacce P.L.; Parker G.J.M.; Hollow Polycaprolactone microspheres with\/without a single surface hole by co-electrospraying. Langmuir 2017,33(46),13262-13271","journal-title":"Langmuir"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43094-020-00167-2","volume":"7","author":"Nyamweya N.N.","year":"2021","unstructured":"Nyamweya N.N.; Applications of polymer blends in drug delivery. Future J Pharmaceut Sci 2021,7(1),18","journal-title":"Future J Pharmaceut Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1016\/j.biomaterials.2012.06.013","volume":"33","author":"Liu Y.","year":"2012","unstructured":"Liu Y.; Ghassemi A.H.; Hennink W.E.; Schwendeman S.P.; The microclimate pH in poly(d,l-lactide-co-hydroxymethyl glycolide) microspheres during biodegradation. Biomaterials 2012,33(30),7584-7593","journal-title":"Biomaterials"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jconrel.2004.07.029","volume":"101","author":"Li L","year":"2005","unstructured":"Li L; Schwendeman S P;  Mapping neutral microclimate PH in PLGA microspheres. J Control Release 2005,101(1-3 SPEC. ISS.),163-73","journal-title":"J Control Release"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","volume":"122","author":"Zolnik B.S.","year":"2007","unstructured":"Zolnik B.S.; Burgess D.J.; Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 2007,122(3),338-344","journal-title":"J Control Release"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","volume":"12","author":"Allahyari M.","year":"2016","unstructured":"Allahyari M.; Mohit E.; Peptide\/protein vaccine delivery system based on PLGA particles. Hum Vaccin Immunother 2016,12(3),806-828","journal-title":"Hum Vaccin Immunother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1021\/acs.molpharmaceut.7b00586","volume":"14","author":"Bailey B.A.","year":"2017","unstructured":"Bailey B.A.; Desai K.G.H.; Ochyl L.J.; Ciotti S.M.; Moon J.J.; Schwendeman S.P.; Self-encapsulating Poly(lactic- co -glycolic acid) (PLGA) microspheres for intranasal vaccine delivery. Mol Pharm 2017,14(9),3228-3237","journal-title":"Mol Pharm"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1023\/A:1013090700443","volume":"18","author":"Woo B.H.","year":"2001","unstructured":"Woo B.H.; Jiang G.; Jo Y.W.; DeLuca P.P.; Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res 2001,18(11),1600-1606","journal-title":"Pharm Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"17736","DOI":"10.1039\/c4ra00788c","volume":"4","author":"Zhao J.","year":"2014","unstructured":"Zhao J.; Guo B.; Ma P.X.; Injectable alginate microsphere\/PLGA\u2013PEG\u2013PLGA composite hydrogels for sustained drug release. RSC Advances 2014,4(34),17736-17742","journal-title":"RSC Advances"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/17435889.2.2.241","volume":"2","author":"van Manen H-J.","year":"2007","unstructured":"van Manen H-J.; van Apeldoorn A.A.; Verrijk R.; van Blitterswijk C.A.; Otto C.; Intracellular degradation of microspheres based on cross-linked dextran hydrogels or amphiphilic block copolymers: a comparative raman microscopy study. Int J Nanomedicine 2007,2(2),241-252","journal-title":"Int J Nanomedicine"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/10717544.2019.1580322","volume":"26","author":"Huang S.","year":"2019","unstructured":"Huang S.; Huang G.; Preparation and drug delivery of dextran-drug complex. Drug Deliv 2019,26(1),252-261","journal-title":"Drug Deliv"},{"key":"ref=85","author":"Daily M.E.D.","unstructured":"Daily M.E.D.; National Library of Medicine. Available from:\n (Accessed on: Jun 1, 2022)."},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2217\/nnm.12.210","volume":"8","author":"De La Vega J.C.","year":"2013","unstructured":"De La Vega J.C.; Elischer P.; Schneider T.; H\u00e4feli U.O.; Uniform polymer microspheres: monodispersity criteria, methods of formation and applications. Nanomedicine (Lond) 2013,8(2),265-285","journal-title":"Nanomedicine (Lond)"},{"key":"ref=87","author":"Blazejewski Emile","year":"2018","unstructured":"Blazejewski Emile; Method of preparing microparticles by double emulsion. Patent WO 2019\/066649 A1 2018","journal-title":"Patent WO 2019\/066649 A1"},{"key":"ref=88","doi-asserted-by":"publisher","author":"Jo Y.W.","unstructured":"Jo Y.W.; Woo B.H.; Hazrati A.M.; DeLuca P.P.; Use of Pharmasep unit for processing micropheres Available from:   \n(Accessed on: Jun 1, 2022).","DOI":"10.1208\/pt0201_tn2"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/21691401.2018.1469024","volume":"46","author":"Cakir-Koc R","year":"2018","unstructured":"Cakir-Koc R; Budama-Kilinc Y; Kokcu Y; Kecel-Gunduz S; Docking of immunogenic peptide of toxoplasma gondii and encapsulation with polymer as vaccine candidate. Artif Cells Nanomed Biotechnol 2018,46(sup2),744-54","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14484846.2018.1432089","volume":"27","author":"Mohan D.G.","year":"2019","unstructured":"Mohan D.G.; Gopi S.; Rajasekar V.; Investigation of the interactions between melittin and the PLGA and PLA polymers: molecular dynamic simulation and binding free energy calculation. Mater Today Proc 2019,27,31","journal-title":"Mater Today Proc"},{"key":"ref=91","unstructured":"U.S. Food and Drug Administration (FDA). Container closure systems for packaging human drugs and biologics: Chemistry, manufacturing, and controls documentation. Available from: \n (Accessed on: Jun 1, 2022)."},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jps.24184","volume":"104","author":"Krayukhina E.","year":"2015","unstructured":"Krayukhina E.; Tsumoto K.; Uchiyama S.; Fukui K.; Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins. J Pharm Sci 2015,104(2),527-535","journal-title":"J Pharm Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.xphs.2016.02.019","volume":"105","author":"Chisholm C.F.","year":"2016","unstructured":"Chisholm C.F.; Baker A.E.; Soucie K.R.; Torres R.M.; Carpenter J.F.; Randolph T.W.; Silicone oil microdroplets can induce antibody responses against recombinant murine growth hormone in mice. J Pharm Sci 2016,105(5),1623-1632","journal-title":"J Pharm Sci"},{"key":"ref=94","unstructured":"U.S. Food and Drug Administration (FDA). Complex drug products. Available from:\n (Accessed on: Jun 1, 2022)."}],"container-title":["Recent Advances in Drug Delivery and Formulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2667387817666230119103126","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212879\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2667387817666230119103126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:39:33Z","timestamp":1691768373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212879\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2667387817666230119103126","relation":{},"ISSN":["2667-3878"],"issn-type":[{"value":"2667-3878","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}